Markets Stocks Economy Crypto Earnings Banking Energy
Home› Stocks› Feature
Stocks · Exclusive

Three stocks tumble on heavy volume after deal, drug, and financing news

Three stocks tumble on heavy volume after deal, drug, and financing news
Stocks · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Oct 6, 2026 4 min read

Three very different headlines sent three stocks sharply lower on unusually heavy trading volume, a reminder that when investors have to update expectations quickly, the size of the move often depends as much on liquidity as on the news itself.

Seagate Technology slid about 9.5% after Bloomberg reported, citing people familiar with the matter, that the hard-disk drive maker and Japan's Toshiba are competing to buy TDK's magnetic-head unit in a deal that could be worth several billion dollars. Roughly 5.2 million shares traded, versus about 4.6 million on a typical day.

ArriVent BioPharma fell 48% after saying its phase 3 study of firmonertinib missed its main goal of delaying disease progression in a specific type of lung cancer. Volume exploded to about 14.1 million shares, compared with an average of roughly 525,000.

And NFT, a microcap, dropped around 70% after pricing a direct offering to raise about $2.55 million, with volume also above normal.

Why the selloffs were so sharp

These are unrelated stories, but the trading pattern is similar. When a headline forces investors to reassess a company's prospects quickly, they tend to reprice first and ask questions later. The question is how far the price has to fall before enough buyers step in.

In liquid names, like Seagate, which normally trades in size, the market can absorb the scramble with less dislocation. Even a 9.5% drop on a deal report is notable, but the stock can find buyers faster than a small-cap biotech or microcap issuer.

In thinner names, like ArriVent and NFT, the effect is amplified. Each sell order moves the price more, intraday ranges widen, and it can take longer for the stock to settle. Traders often respond by widening the bid-ask spread, the gap between what buyers will pay and what sellers will accept, which makes it even costlier to trade.

Big volume isn't automatically a sign of healthy interest. It can mean the market is struggling to match sellers with buyers. In small caps, that can create what traders call air pockets, where the price gaps down and there's little support until a new equilibrium is found.

What it means for investors

For everyday investors, the key takeaway is that liquidity matters. A stock's daily volume is a rough measure of how easily you can buy or sell without moving the price. When volume spikes on bad news, it often signals that many holders are trying to exit at once, and the price may overshoot before stabilizing.

In the case of Seagate, the selloff is tied to a potential acquisition, not a fundamental deterioration in its business. If the deal goes through, it could change the competitive landscape for hard-disk drive components. But the report is still unconfirmed, and deal talks can fall apart. Investors will likely watch for official statements from Seagate, Toshiba, or TDK.

For ArriVent, the failed trial is a direct hit to its pipeline. The company's main asset, firmonertinib, was being tested for a specific type of lung cancer, and missing the primary endpoint means the drug's future is uncertain. The stock's 48% plunge reflects that the market had assigned significant value to the drug's success. Investors should note that phase 3 failures are not uncommon in biotech, and the stock may remain volatile as the company decides next steps.

For NFT, the direct offering is a classic dilution event. Raising about $2.55 million by selling new shares increases the total share count, which reduces the value of existing shares. The 70% drop suggests the offering was priced at a steep discount to the previous market price. Microcaps like NFT are especially sensitive to dilution because their share counts are small and their investor bases are thin.

These three stories also highlight a broader market reality: surprises are hard to value in real time. Whether it's a takeover, a drug trial, or a financing, the initial price move is often a rough guess. For investors, the lesson is to be cautious when trading on headline news, especially in less liquid stocks, and to remember that the price you see may not reflect the true value until the market has had time to digest the information.

For more on how liquidity and volume can drive outsized moves, see our earlier piece on small-cap stocks surging on deal news. And for a look at how broader market sentiment can shift, check out Asian markets rallying on AI chip strength.

More from this story

Next article · Don't miss

Codelco names coordinator for Los Bronces JV ahead of key permit filings

Codelco has reshuffled management for its planned copper joint venture with Anglo American, appointing Claudia Monreal Lopez to coordinate all internal teams. The move comes as both partners prepare separate environmental permit filings in December, a key test

Read the story →
Codelco names coordinator for Los Bronces JV ahead of key permit filings